The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the False Claims Act (FCA) by causing the submission of false claims for the transmucosal immediate-release fentanyl (TIRF) Read More
Home » Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Related Posts
Nevada Man Sentenced to 46 Months in Prison for Threatening U.S.
A Las Vegas man who pleaded guilty to threatening a U.S. Senator from Nevada and threatening family members of two United States Senators was sentenced… BronNevada Man Sentenced to 46 Months in Prison for Threatening U.S.
New Hampshire Doctor Pleads Guilty to Illegally Prescribing Opioids
A New Hampshire doctor pleaded guilty today to unlawfully distributing a controlled substance. Read More
Delaware Man Convicted of Sex Trafficking and Forced Labor
A federal jury in the District of Delaware convicted Clifton H. Gibbs, 68, of Sussex County today on multiple counts of sex trafficking and forced… BronDelaware Man Convicted of Sex Trafficking and Forced Labor